Rosuvastatin/Ezetimibe
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Rosuvastatin/Ezetimibe, covering 2019-07-23 to 2025-11-25. Get the full timeline:
Most recent: Clinical Trial Update: Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial) [Phase 4]